BrainsWay Ltd. (BRSYF)
PNK · Healthcare · Medical Devices
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About BrainsWay Ltd.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 12.6M | 13.5M | 14.5M | 15.5M |
| Gross Profit | 9.5M | 10.2M | 11.1M | 11.7M |
| Operating Income | 578K | 1.3M | 1.9M | 2.0M |
| Net Income | 2.0M | 1.6M | 2.9M | 2.3M |
| Diluted EPS | $0.05 | $0.04 | $0.07 | $0.06 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 27.2M | 31.8M | 41.0M | 52.2M |
| Gross Profit | 20.0M | 23.5M | 30.6M | 39.4M |
| Operating Income | -12.7M | -5.0M | 1.4M | 4.3M |
| Net Income | -13.3M | -4.2M | 2.9M | 7.6M |
| Diluted EPS | $-0.40 | $-0.13 | $0.09 | $0.18 |